A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
British Journal of Cancer, 08/10/2012
Proctor MJ et al. – The results of the present study show that the dNLR has similar prognostic value to the neutrophil lymphocyte ratio (NLR). Therefore, the universally available dNLR is to be commended for use in the risk stratification of patients undergoing chemotherapy.